Overview
- 15 FDA inspections are on record.
- 8 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-07-25.
At a glance
Inspections
15
Form 483s
8
EIRs
1
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 21 Jul 2025 – 25 Jul 2025 | Human Drugs | 483 | On file |
| 24 Feb 2020 – 13 Mar 2020 | Human Drugs | 483 | On file |
| 31 Jul 2018 – 7 Aug 2018 | Human Drugs | Clean | |
| 23 Mar 2018 – 26 Mar 2018 | Animal Drugs & Feeds | Clean | |
| 25 Jun 2015 – 1 Jul 2015 | Human Drugs | WL | View 483 → |
| 15 Jul 2013 – 24 Jul 2013 | Human Drugs | 483 | View 483 → |
| 16 Mar 2012 | Not recorded | 483 | View 483 → |
| 29 Apr 2011 | Not recorded | 483 | On file |
| 26 Mar 2010 | Not recorded | 483 | View 483 → |
| 24 Apr 2009 | Not recorded | 483 | View 483 → |
| 15 Oct 2008 | Not recorded | Clean | |
| 1 Sep 2006 | Not recorded | Clean | |
Observations on record
Form 483 observations cited at this site, most recent first.
1 Jul 2015
21 CFR 211.100(a)
Absence of Written Procedures
Cited by Yasamin Ameri, Yumi J Hiramine, Carlos Chavez
1 Jul 2015
21 CFR 211.100(a)
Absence of Written Procedures
Cited by Yasamin Ameri, Yumi J Hiramine, Carlos Chavez
1 Jul 2015
21 CFR 211.160(b)(1)
Sampling and testing procedures described
Cited by Yasamin Ameri, Yumi J Hiramine, Carlos Chavez
1 Jul 2015
21 CFR 211.160(b)(1)
Sampling and testing procedures described
Cited by Yasamin Ameri, Yumi J Hiramine, Carlos Chavez
Investigators
FDA investigators tied to this site in the record.
Shatina R Alridge2 insp.
Scott T Ballard2 insp.
Timothy H Vo1 insp.
Margaret M Annes1 insp.
Michelle A Krayer1 insp.
Shanna N Purdy1 insp.
Yasamin Ameri1 insp.
Yumi J Hiramine1 insp.
Carlos Chavez1 insp.
Elizabeth D Connell1 insp.
Hala L Selby1 insp.
Jodi M Gatica1 insp.
Trina K Vick1 insp.
Qing Delgado1 insp.
Sean C Johnson1 insp.
State Agency1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 6x |
| 21 CFR 211.67(a) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.67(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.68(a) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.160(b)(1) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.165(e) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.166(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.180(e) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.194(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.63 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.67(b)(2) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.67(c) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.113(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.115(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.166(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.180(e)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(8) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.56(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.58 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.80(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(d)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(d)(2) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Pharma Nobis LLC's 8 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat